Stock UFPT UFP TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials UFP Technologies, Inc.

Equities

UFPT

US9026731029

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
213.2 USD +1.72% Intraday chart for UFP Technologies, Inc. +2.56% +23.95%
20/03 CJS Securities Initiates UFP Technologies With Market Outperform Rating, $255 Price Target MT
05/03 North American Morning Briefing : S&P 500 Futures -2- DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 369 349.3 529.2 893.4 1,314 1,630 -
Enterprise Value (EV) 1 369 349.3 602.1 957.4 1,314 1,630 1,630
P/E ratio 18.9 x 38.2 x 33.6 x 21.6 x 29.5 x 36 x 31.5 x
Yield - - - - - - -
Capitalization / Revenue 1.86 x 1.95 x 2.56 x 2.53 x 3.28 x 3.77 x 3.48 x
EV / Revenue 1.86 x 1.95 x 2.56 x 2.53 x 3.28 x 3.77 x 3.48 x
EV / EBITDA - 14 x 17.6 x 15 x 17 x 20.3 x 17.9 x
EV / FCF - 1,69,05,801 x 5,94,69,152 x 22,53,88,952 x - - -
FCF Yield - 0% 0% 0% - - -
Price to Book - 1.97 x 2.72 x 3.76 x - - -
Nbr of stocks (in thousands) 7,437 7,495 7,531 7,579 7,639 7,642 -
Reference price 2 49.61 46.60 70.26 117.9 172.0 213.2 213.2
Announcement Date 04/03/20 04/03/21 08/03/22 07/03/23 21/02/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 198.4 179.4 206.3 353.8 400.1 431.7 468.5
EBITDA 1 - 25 30.06 59.64 77.27 80.18 91.23
EBIT 1 24.71 16.73 21.65 55.4 57.66 62.71 72.98
Operating Margin 12.45% 9.33% 10.49% 15.66% 14.41% 14.52% 15.58%
Earnings before Tax (EBT) 1 23.65 16.28 21.2 52.72 53.9 61.61 72.96
Net income 1 19.75 13.37 15.89 41.79 44.92 46.43 54.51
Net margin 9.96% 7.45% 7.7% 11.81% 11.23% 10.76% 11.63%
EPS 2 2.630 1.220 2.090 5.450 5.830 5.930 6.767
Free Cash Flow - 20.66 8.898 3.964 - - -
FCF margin - 11.52% 4.31% 1.12% - - -
FCF Conversion (EBITDA) - 82.64% 29.6% 6.65% - - -
FCF Conversion (Net income) - 154.53% 56.01% 9.49% - - -
Dividend per Share - - - - - - -
Announcement Date 04/03/20 04/03/21 08/03/22 07/03/23 21/02/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 50.72 56.34 71.24 94.34 96.97 91.24 97.75 100 100.8 101.5 97.3 105.2 112.6 116.6
EBITDA 1 7.268 7.11 9.376 9.561 29.67 11.04 19.45 21.39 19.35 17.07 16.21 18.39 22.08 23.8
EBIT 1 5.077 4.909 6.36 6.244 10.34 10.88 12.84 17.04 15.04 12.74 11.85 14.35 17.65 18.86
Operating Margin 10.01% 8.71% 8.93% 6.62% 10.67% 11.92% 13.14% 17.04% 14.93% 12.55% 12.18% 13.63% 15.67% 16.17%
Earnings before Tax (EBT) 1 5.057 4.629 6.085 11.62 25.24 9.771 11.9 15.97 14.14 11.89 10.96 13.54 17.75 19.31
Net income 1 3.789 3.218 4.858 8.929 19.54 8.462 9.739 11.88 11.69 11.61 8.544 10.51 13.19 14.22
Net margin 7.47% 5.71% 6.82% 9.46% 20.15% 9.27% 9.96% 11.88% 11.6% 11.44% 8.78% 9.99% 11.72% 12.19%
EPS 2 0.5000 0.4200 0.6400 1.170 2.560 1.100 1.270 1.550 1.520 1.510 1.097 1.347 1.677 1.797
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 03/11/21 08/03/22 04/05/22 02/08/22 02/11/22 07/03/23 02/05/23 01/08/23 01/11/23 21/02/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - 73 63.9 - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - 2.428 x 1.072 x - - -
Free Cash Flow - 20.7 8.9 3.96 - - -
ROE (net income / shareholders' equity) - 7.89% 8.56% 19.3% - 13.9% 13.1%
ROA (Net income/ Total Assets) - 6.82% 5.91% 11.7% - 10.7% 10.5%
Assets 1 - 196 268.7 355.8 - 434 519.1
Book Value Per Share - 23.70 25.80 31.30 - - -
Cash Flow per Share - - - - - - -
Capex 1 5.78 4.37 5.4 13.8 - 11.4 12.6
Capex / Sales 2.91% 2.44% 2.61% 3.89% - 2.64% 2.68%
Announcement Date 04/03/20 04/03/21 08/03/22 07/03/23 21/02/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for UFP Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
213.2 USD
Average target price
243 USD
Spread / Average Target
+13.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
UFP TECHNOLOGIES, INC. Stock UFP Technologies, Inc.
+23.95% 1.63B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. UFPT Stock
  4. Financials UFP Technologies, Inc.